Administration of anti-IL-25 antibodies in mice with ovalbumin- (41) or HDM- and adenoviral smad2–overexpression-induced asthma (42) significantly decreased the Th2 immune responses and attenuated AHR and airway tissue remodeling. The gene discussed is IL25; the disease is asthma.